SPM Corp

VN:SPM Vietnam Drug Manufacturers - Specialty & Generic
Market Cap
$3.57K
₫90.64 Million VND
Market Cap Rank
#34570 Global
#298 in Vietnam
Share Price
₫9500.00
Change (1 day)
+5.56%
52-Week Range
₫9000.00 - ₫12400.00
All Time High
₫30306.51
About

SPM Corporation manufactures and sells pharmaceutical products in Vietnam. The company engages in the trading of food products; wholesale of dietary supplements; retail of raw materials to produce medical machinery and equipment, masks, gloves, personal protective equipment; retail of medicine; manufacture of dietary supplements; and leasing of assets. It also offers products in various therapeut… Read more

SPM Corp (SPM) - Net Assets

Latest net assets as of : ₫- VND

Based on the latest financial reports, SPM Corp (SPM) has net assets worth ₫- VND as of .

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₫-) and total liabilities (₫-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ₫-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

SPM Corp - Net Assets Trend (None–None)

This chart illustrates how SPM Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for SPM Corp (None–None)

The table below shows the annual net assets of SPM Corp from None to None.

Year Net Assets Change
No yearly data available.

Equity Component Analysis

This analysis shows how different components contribute to SPM Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

SPM Corp Competitors by Market Cap

The table below lists competitors of SPM Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in SPM Corp's equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares SPM Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently SPM Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Insufficient data available to analyze capital efficiency metrics.

Industry Comparison

This section compares SPM Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $1,979,636,361,615
  • Average return on equity (ROE) among peers: 16.56%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
SPM Corp (SPM) ₫- N/A N/A $1.80 Million
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) $1.66 Trillion 16.57% 0.36x $183.29 Million
DHG Pharmaceutical JSC (DHG) $3.57 Trillion 20.74% 0.25x $29.78 Million
DOMESCO Medical Import Export JSC (DMC) $1.25 Trillion 18.58% 0.22x $21.40K
Imexpharm Corp (IMP) $1.73 Trillion 12.12% 0.21x $119.65 Million
Traphaco JSC (TRA) $1.69 Trillion 14.81% 0.39x $27.57 Million